What influences the uptake of the human papillomavirus (HPV) vaccine in males: a public health approach
In the UK vaccination programme, HPV vaccination is predominantly promoted as a female public health concern, and vaccination is aimed at girls aged 12–13 years old. Recent studies in HPV vaccination have shown health benefits for males in the prevention of ano-genital and penile cancer and genital warts. Despite male vaccination being supported by significant national and international organisations, in the UK it has come down to a cost-effectiveness issue, which raises many ethical questions.
Faculty of Nursing, Manchester Metropolitan University